<code id='49352680E4'></code><style id='49352680E4'></style>
    • <acronym id='49352680E4'></acronym>
      <center id='49352680E4'><center id='49352680E4'><tfoot id='49352680E4'></tfoot></center><abbr id='49352680E4'><dir id='49352680E4'><tfoot id='49352680E4'></tfoot><noframes id='49352680E4'>

    • <optgroup id='49352680E4'><strike id='49352680E4'><sup id='49352680E4'></sup></strike><code id='49352680E4'></code></optgroup>
        1. <b id='49352680E4'><label id='49352680E4'><select id='49352680E4'><dt id='49352680E4'><span id='49352680E4'></span></dt></select></label></b><u id='49352680E4'></u>
          <i id='49352680E4'><strike id='49352680E4'><tt id='49352680E4'><pre id='49352680E4'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:8311
          Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT
          Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

          The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

          advertisement

          Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Lack of darker skin in textbooks, journals harms patients of color
          Lack of darker skin in textbooks, journals harms patients of color

          HyacinthEmpinado/STATWhendermatologistJennaLesterlearnedthatrashesonskinandtoeswereasymptomofCovid-1

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Ultragenyx gene therapy for rare liver ailment succeeds in late

          JonathanWiggs/GlobeStaffUltragenyxsaidThursdayafternoonthatitsgenetherapyforarareliverailment,glycog